title: Epigenetic and pharmacological regulation of the amyloid-degrading enzyme neprilysin results in modulation of cognitive functions in mammals.
authors: Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences, St. Petersburg, 194223, Russia, zhuravin@iephb.ru.
authors: I A
authors: IA
authors: Zhuravin
authors: N M
authors: NM
authors: Dubrovskaya
authors: D S
authors: DS
authors: Vasilev
authors: N L
authors: NL
authors: Tumanova
authors: N N
authors: NN
authors: Nalivaeva
mesh_terms: D000818:Animals; D044127:Epigenesis, Genetic; D008297:Male; D018782:Maze Learning; D008570:Memory, Short-Term; D019579:Neocortex / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D015260:Neprilysin / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014635:Valproic Acid / Q000494:pharmacology
chemical_list: D014635:Valproic Acid; D015260:Neprilysin